Avaliação de massa mamária

Referências

Principais artigos

American Cancer Society. Breast cancer facts and figures 2019-2020. 2019 [internet publication]Texto completo

Dupont WD, Page DL, Parl FF, et al. Long-term risk of breast cancer in women with fibroadenoma. N Engl J Med. 1994 Jul 7;331(1):10-5.Texto completo  Resumo

Dupont WD, Page DL. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med. 1985 Jan 17;312(3):146-51. Resumo

American College of Radiology. ACR practice parameter for the performance of ultrasound-guided percutaneous breast interventional procedures. 2016 [internet publication].Texto completo

Artigos de referência

1. Barton MB, Elmore JG, Fletcher SW. Breast symptoms among women enrolled in a health maintenance organization: frequency, evaluation, and outcome. Ann Intern Med. 1999 Apr 20;130(8):651-7. Resumo

2. Beyer T, Moonka R. Normal mammography and ultrasonography in the setting of palpable breast cancer. Am J Surg. 2003 May;185(5):416-9. Resumo

3. Vetto JT, Pommier RF, Schmidt WA, et al. Diagnosis of palpable breast lesions in younger women by the modified triple test is accurate and cost-effective. Arch Surg. 1996 Sep;131(9):967-72. Resumo

4. Vetto JT, Pommier RF, Schmidt WA, et al. Use of the "triple test" for palpable breast lesions yields high diagnostic accuracy and cost savings. Am J Surg. 1995 May;169(5):519-22. Resumo

5. Morris A, Pommier RF, Schmidt WA, et al. Accurate evaluation of palpable breast masses by the triple test score. Arch Surg. 1998 Sep;133(9):930-4.Texto completo  Resumo

6. American Cancer Society. Breast cancer facts and figures 2019-2020. 2019 [internet publication]Texto completo

7. Abdelwahab Yousef AJ. Male Breast Cancer: Epidemiology and Risk Factors. Semin Oncol. 2017 Aug;44(4):267-272.Texto completo  Resumo

8. Dent DM, Cant PJ. Fibroadenoma. World J Surg. 1989 Nov-Dec;13(6):706-10. Resumo

9. Martin PM, Kuttenn F, Serment H, et al. Studies on clinical, hormonal and pathological correlations in breast fibroadenomas. J Steroid Biochem. 1978 Dec;9(12):1251-5. Resumo

10. Dupont WD, Page DL, Parl FF, et al. Long-term risk of breast cancer in women with fibroadenoma. N Engl J Med. 1994 Jul 7;331(1):10-5.Texto completo  Resumo

11. Nassar A, Visscher DW, Degnim AC, et al. Complex fibroadenoma and breast cancer risk: a Mayo Clinic benign breast disease cohort study. Breast Cancer Res Treat. 2015 Sep;153(2):397-405.Texto completo  Resumo

12. Tan BY, Acs G, Apple SK, et al. Phyllodes tumours of the breast: a consensus review. Histopathology. 2016 Jan;68(1):5-21.Texto completo  Resumo

13. Frantz VK, Pickren JW, Melcher GW, et al. Incidence of chronic cystic disease in so-called "normal" breasts; a study based on 225 postmortem examinations. Cancer. 1951 Jul;4(4):762-83. Resumo

14. Ross RK, Paganini-Hill A, Wan PC, et al. Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin. J Natl Cancer Inst. 2000 Feb 16;92(4):328-32.Texto completo  Resumo

15. Stavros AT, Thickman D, Rapp CL, et al. Solid breast nodules: use of sonography to distinguish between benign and malignant lesions. Radiology. 1995 Jul;196(1):123-34. Resumo

16. Houssami N, Irwig L, Ung O. Review of complex breast cysts: implications for cancer detection and clinical practice. ANZ J Surg. 2005 Dec;75(12):1080-5. Resumo

17. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: breast cancer screening and diagnosis [internet publication].Texto completo

18. Baker TP, Lenert JT, Parker J, et al. Lactating adenoma: a diagnosis of exclusion. Breast J. 2001 Sep-Oct;7(5):354-7. Resumo

19. Beute BJ, Kalisher L, Hutter RV. Lobular carcinoma in situ of the breast: clinical, pathologic, and mammographic features. AJR Am J Roentgenol. 1991 Aug;157(2):257-65.Texto completo  Resumo

20. Winchester DP, Jeske JM, Goldschmidt RA. The diagnosis and management of ductal carcinoma in-situ of the breast. CA Cancer J Clin. 2000 May-Jun;50(3):184-200.Texto completo  Resumo

21. Public Health England. NHS breast screening programme clinical guidance for breast cancer screening assessment. November 2016 [internet publication].Texto completo

22. Winchester DJ, Bernstein JR, Jeske JM, et al. Upstaging of atypical ductal hyperplasia after vacuum-assisted 11-gauge stereotactic core needle biopsy. Arch Surg. 2003 Jun;138(6):619-22.Texto completo  Resumo

23. Guth U, Huang DJ, Huber M, et al. Tumor size and detection in breast cancer: self-examination and clinical breast examination are at their limit. Cancer Detect Prev. 2008;32(3):224-8. Resumo

24. Breen N, Yabroff KR, Meissner HI. What proportion of breast cancers are detected by mammography in the United States? Cancer Detect Prev. 2007;31(3):220-4. Resumo

25. Benson JR, Jatoi I, Keisch M, et al. Early breast cancer. Lancet. 2009 Apr 25;373(9673):1463-79. Resumo

26. Lynch HT, Silva E, Snyder C, et al. Hereditary breast cancer - part I: diagnosing hereditary breast cancer syndromes. Breast J. 2008 Jan-Feb;14(1):3-13. Resumo

27. Dupont WD, Page DL. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med. 1985 Jan 17;312(3):146-51. Resumo

28. Marshall LM, Hunter DJ, Connolly JL, et al. Risk of breast cancer associated with atypical hyperplasia of lobular and ductal types. Cancer Epidemiol Biomarkers Prev. 1997 May;6(5):297-301.Texto completo  Resumo

29. Sakorafas GH, Krespis E, Pavlakis G. Risk estimation for breast cancer development; a clinical perspective. Surg Oncol. 2002 May;10(4):183-92. Resumo

30. National Institute for Health and Care Excellence. Menopause: diagnosis and management. November 2015 [internet publication].Texto completo

31. de Villiers TJ, Hall JE, Pinkerton JV, et al. Revised global consensus statement on menopausal hormone therapy. Climacteric. 2016 Aug;19(4):313-5. Resumo

32. Shapley M, Mansell G, Jordan JL, et al. Positive predictive values of ≥5% in primary care for cancer: systematic review. Br J Gen Pract. 2010 Sep;60(578):e366-77. Resumo

33. Hindle WH. Breast mass evaluation. Clin Obstet Gynecol. 2002 Sep;45(3):750-7. Resumo

34. Goodson WH 3rd, Hunt TK, Plotnik JN, et al. Optimization of clinical breast examination. Am J Med. 2010 Apr;123(4):329-34. Resumo

35. American College of Radiology. ACR appropriateness criteria: palpable breast masses. 2016 [internet publication].Texto completo

36. Malur S, Wurdinger S, Moritz A, et al. Comparison of written reports of mammography, sonography and magnetic resonance mammography for preoperative evaluation of breast lesions, with special emphasis on magnetic resonance mammography. Breast Cancer Res. 2001;3(1):55-60.Texto completo  Resumo

37. Kerlikowske K, Grady D, Rubin SM, et al. Efficacy of screening mammography: a meta-analysis. JAMA. 1995 Jan 11;273(2):149-54. Resumo

38. Kacl GM, Liu P, Debatin JF, et al. Detection of breast cancer with conventional mammography and contrast-enhanced MR imaging. Eur Radiol. 1998;8(2):194-200. Resumo

39. Bone B, Pentek Z, Perbeck L, et al. Diagnostic accuracy of mammography and contrast-enhanced MR imaging in 238 histologically verified breast lesions. Acta Radiol. 1997 Jul;38(4 pt 1):489-96. Resumo

40. National Institute for Health and Care Excellence. Suspected cancer: recognition and referral. Dec 2021 [internet publication].Texto completo

41. Kerlikowske K, Smith-Bindman R, Ljung BM, et al. Evaluation of abnormal mammography results and palpable breast abnormalities. Ann Intern Med. 2003 Aug 19;139(4):274-84. Resumo

42. Cox B, Ballard-Barbash R, Broeders M, et al; International Cancer Screening Network. Recording of hormone therapy and breast density in breast screening programs: summary and recommendations of the International Cancer Screening Network. Breast Cancer Res Treat. 2010 Dec;124(3):793-800. Resumo

43. Woods RW, Sisney GS, Salkowski LR, et al. The mammographic density of a mass is a significant predictor of breast cancer. Radiology. 2011 Feb;258(2):417-25. Resumo

44. American College of Radiology. ACR practice parameter for the performance of a breast ultrasound examination. 2016 [internet publication].Texto completo

45. Kolb TM, Lichy J, Newhouse JH. Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: an analysis of 27,825 patient evaluations. Radiology. 2002 Oct;225(1):165-75.Texto completo  Resumo

46. Max MH, Klamer TW. Breast cancer in 120 women under 35 years old: a 10-year community-wide survey. Am Surg. 1984 Jan;50(1):23-5. Resumo

47. Cardoso F, Kyriakides S, Ohno S, et al.Early Breast Cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. ESMO. 2019 Aug 01;30(8);1194-220.Texto completo

48. American College of Radiology. ACR practice parameter for the performance of ultrasound-guided percutaneous breast interventional procedures. 2016 [internet publication].Texto completo

49. Gong X, Xu Q, Xu Z, et al. Real-time elastography for the differentiation of benign and malignant breast lesions: a meta-analysis. Breast Cancer Res Treat. 2011 Nov;130(1):11-8. Resumo

50. Sadigh G, Carlos RC, Neal CH, et al. Ultrasonographic differentiation of malignant from benign breast lesions: a meta-analytic comparison of elasticity and BIRADS scoring. Breast Cancer Res Treat. 2012 May;133(1):23-35. Resumo

51. Sadigh G, Carlos RC, Neal CH, et al. Accuracy of quantitative ultrasound elastography for differentiation of malignant and benign breast abnormalities: a meta-analysis. Breast Cancer Res Treat. 2012 Aug;134(3):923-31. Resumo

52. Medeiros LR, Duarte CS, Rosa DD, et al. Accuracy of magnetic resonance in suspicious breast lesions: a systematic quantitative review and meta-analysis. Breast Cancer Res Treat. 2011 Apr;126(2):273-85. Resumo

53. Peters NH, Borel Rinkes IH, Zuithoff NP, et al. Meta-analysis of MR imaging in the diagnosis of breast lesions. Radiology. 2008 Jan;246(1):116-24.Texto completo  Resumo

54. Hassan HHM, El Abd AM, Abdel Bary A, et al. Fat Necrosis of the Breast: Magnetic Resonance Imaging Characteristics and Pathologic Correlation. Acad Radiol. 2018 Aug;25(8):985-992.Texto completo  Resumo

55. Siu AL; US Preventive Services Task Force. Screening for breast cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2016 Feb 16;164(4):279-96.Texto completo  Resumo

56. Chen X, Li WL, Zhang YL, et al. Meta-analysis of quantitative diffusion-weighted MR imaging in the differential diagnosis of breast lesions. BMC Cancer. 2010 Dec 29;10:693.Texto completo  Resumo

57. Akçil M, Karaağaoğlu E, Demirhan B. Diagnostic accuracy of fine-needle aspiration cytology of palpable breast masses: an SROC curve with fixed and random effects linear meta-regression models. Diagn Cytopathol. 2008 May;36(5):303-10. Resumo

58. Yu YH, Wei W, Liu JL. Diagnostic value of fine-needle aspiration biopsy for breast mass: a systematic review and meta-analysis. BMC Cancer. 2012 Jan 25;12:41.Texto completo  Resumo

59. Yu YH, Liang C, Yuan XZ. Diagnostic value of vacuum-assisted breast biopsy for breast carcinoma: a meta-analysis and systematic review. Breast Cancer Res Treat. 2010 Apr;120(2):469-79. Resumo

60. National Institute for Health and Care Excellence. Image-guided radiofrequency excision biopsy of breast lesions. July 2009 [internet publication].Texto completo

61. Hahn M, Krainick-Strobel U, Toellner T, et al. Interdisciplinary consensus recommendations for the use of vacuum-assisted breast biopsy under sonographic guidance: first update 2012. Ultraschall Med. 2012 Aug;33(4):366-71. Resumo

62. Hindle WH, Arias RD, Florentine B, et al. Lack of utility in clinical practice of cytologic examination of nonbloody cyst fluid from palpable breast cysts. Am J Obstet Gynecol. 2000 Jun;182(6):1300-5. Resumo

O uso deste conteúdo está sujeito ao nosso aviso legal